Cargando…

Recognizing the Benefits of Pre-/Probiotics in Metabolic Syndrome and Type 2 Diabetes Mellitus Considering the Influence of Akkermansia muciniphila as a Key Gut Bacterium

Metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM) are diseases that can be influenced by the structure of gut microbiota, whose improvement is often neglected in metabolic pathology. This review highlights the following main aspects: the relationship between probiotics/gut microbes with...

Descripción completa

Detalles Bibliográficos
Autores principales: Corb Aron, Raluca Anca, Abid, Areha, Vesa, Cosmin Mihai, Nechifor, Aurelia Cristina, Behl, Tapan, Ghitea, Timea Claudia, Munteanu, Mihai Alexandru, Fratila, Ovidiu, Andronie-Cioara, Felicia Liana, Toma, Mirela Marioara, Bungau, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002498/
https://www.ncbi.nlm.nih.gov/pubmed/33802777
http://dx.doi.org/10.3390/microorganisms9030618
Descripción
Sumario:Metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM) are diseases that can be influenced by the structure of gut microbiota, whose improvement is often neglected in metabolic pathology. This review highlights the following main aspects: the relationship between probiotics/gut microbes with the pathogenesis of MetS, the particular positive roles of Akkermansia muciniphila supplementation in the onset of MetS, and the interaction between dietary polyphenols (prebiotics) with gut microbiota. Therefore, an extensive and in-depth analysis of the often-neglected correlation between gut microbiota and chronic metabolic diseases was conducted, considering that this topic continues to fascinate and stimulate researchers through the discovery of novel strains and their beneficial properties.